Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 481

1.

The journal behind the nodes of Ranvier?

Mathis S, Vallat JM.

Lancet Neurol. 2019 Jul;18(7):628. doi: 10.1016/S1474-4422(19)30203-0. No abstract available.

PMID:
31202467
2.

Does intravenous immunoglobulin therapy in Guillain-Barré syndrome patients interfere with serological Zika detection?

Karnam A, Stephen-Victor E, Das M, Magy L, Vallat JM, Bolgert F, Simon-Loriere E, Kaveri SV, Sakuntabhai A, Bayry J.

Autoimmun Rev. 2019 Jun;18(6):632-633. doi: 10.1016/j.autrev.2019.01.004. Epub 2019 Apr 5. No abstract available.

PMID:
30959213
3.

Canine neuropathies: powerful spontaneous models for human hereditary sensory neuropathies.

Correard S, Plassais J, Lagoutte L, Botherel N, Thibaud JL, Hédan B, Richard L, Lia AS, Delague V, Mège C, Mathis S, Guaguère E, Paradis M, Vallat JM, Quignon P, André C.

Hum Genet. 2019 May;138(5):455-466. doi: 10.1007/s00439-019-02003-x. Epub 2019 Apr 6. Review.

PMID:
30955094
4.

Genetics of amyotrophic lateral sclerosis: A review.

Mathis S, Goizet C, Soulages A, Vallat JM, Masson GL.

J Neurol Sci. 2019 Apr 15;399:217-226. doi: 10.1016/j.jns.2019.02.030. Epub 2019 Feb 21. Review.

PMID:
30870681
5.

Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo.

Manso C, Querol L, Lleixà C, Poncelet M, Mekaouche M, Vallat JM, Illa I, Devaux JJ.

J Clin Invest. 2019 Mar 14;130:2222-2236. doi: 10.1172/JCI124694.

6.

Rodent models with expression of PMP22: Relevance to dysmyelinating CMT and HNPP.

Jouaud M, Mathis S, Richard L, Lia AS, Magy L, Vallat JM.

J Neurol Sci. 2019 Mar 15;398:79-90. doi: 10.1016/j.jns.2019.01.030. Epub 2019 Jan 21. Review.

PMID:
30685714
7.

Peripheral nerve regeneration and intraneural revascularization.

Caillaud M, Richard L, Vallat JM, Desmoulière A, Billet F.

Neural Regen Res. 2019 Jan;14(1):24-33. doi: 10.4103/1673-5374.243699. Review.

8.

Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with Nf1 Knockout in Boundary Cap Cells.

Radomska KJ, Coulpier F, Gresset A, Schmitt A, Debbiche A, Lemoine S, Wolkenstein P, Vallat JM, Charnay P, Topilko P.

Cancer Discov. 2019 Jan;9(1):130-147. doi: 10.1158/2159-8290.CD-18-0156. Epub 2018 Oct 22.

PMID:
30348676
9.

Some new proposals for the classification of inherited myopathies.

Mathis S, Tazir M, Solé G, Magy L, Le Masson G, Couratier P, Ghorab K, Duval F, Lacoste I, Goizet C, Vallat JM.

J Neurol Sci. 2018 Aug 15;391:118-119. doi: 10.1016/j.jns.2018.06.014. Epub 2018 Jun 19. No abstract available.

PMID:
30103959
10.

The classification of Charcot-Marie-Tooth diseases, a never-ending story: CMT4?

Vallat JM, Tazir M, Magy L, Le Masson G, Mathis S.

Brain. 2018 Sep 1;141(9):e70. doi: 10.1093/brain/awy207. No abstract available.

PMID:
30084872
11.

Local low dose curcumin treatment improves functional recovery and remyelination in a rat model of sciatic nerve crush through inhibition of oxidative stress.

Caillaud M, Chantemargue B, Richard L, Vignaud L, Favreau F, Faye PA, Vignoles P, Sturtz F, Trouillas P, Vallat JM, Desmoulière A, Billet F.

Neuropharmacology. 2018 Sep 1;139:98-116. doi: 10.1016/j.neuropharm.2018.07.001. Epub 2018 Jul 3.

PMID:
30018000
12.

Pathology of Nerve Biopsy and Diagnostic Yield of PCR-Based Clonality Testing in Neurolymphomatosis.

Duchesne M, Roussellet O, Maisonobe T, Gachard N, Rizzo D, Armand M, Viala K, Richard L, Delage-Corre M, Jaccard A, Corcia P, Vallat JM, Magy L.

J Neuropathol Exp Neurol. 2018 Sep 1;77(9):769-781. doi: 10.1093/jnen/nly055.

PMID:
30011033
13.

Value of nerve biopsy in the management of peripheral neuropathies.

Mathis S, Magy L, Le Masson G, Richard L, Soulages A, Solé G, Duval F, Ghorab K, Vallat JM, Duchesne M.

Expert Rev Neurother. 2018 Jul;18(7):589-602. doi: 10.1080/14737175.2018.1489240. Epub 2018 Jun 25. Review.

PMID:
29923431
14.

Subacute nodopathy with conduction blocks and anti-neurofascin 140/186 antibodies: an ultrastructural study.

Vallat JM, Mathis S, Magy L, Bounolleau P, Skarzynski M, Heitzmann A, Manso C, Devaux J, Uncini A.

Brain. 2018 Jul 1;141(7):e56. doi: 10.1093/brain/awy134. No abstract available.

PMID:
29800077
15.

Assessing sudomotor impairment in patients with peripheral neuropathy: Comparison between electrochemical skin conductance and skin biopsy.

Duchesne M, Richard L, Vallat JM, Magy L.

Clin Neurophysiol. 2018 Jul;129(7):1341-1348. doi: 10.1016/j.clinph.2018.04.608. Epub 2018 Apr 27.

PMID:
29729587
16.

Peripheral nervous system involvement in Leber's hereditary optic neuropathy.

Ciron J, Baron C, Boissonnot M, Neau JP, Magdelaine C, Vallat JM, Mathis S.

J Neurol Sci. 2018 May 15;388:94-96. doi: 10.1016/j.jns.2018.03.002. Epub 2018 Mar 2. No abstract available.

PMID:
29627039
17.

Updating the classification of inherited neuropathies: Results of an international survey.

Magy L, Mathis S, Le Masson G, Goizet C, Tazir M, Vallat JM.

Neurology. 2018 Mar 6;90(10):e870-e876. doi: 10.1212/WNL.0000000000005074. Epub 2018 Feb 2.

PMID:
29429969
18.

Skin Biopsy Findings in Patients With CMT1A: Baseline Data From the CLN-PXT3003-01 Study Provide New Insights Into the Pathophysiology of the Disorder.

Duchesne M, Danigo A, Richard L, Vallat JM, Attarian S, Gonnaud PM, Lacour A, Péréon Y, Stojkovic T, Nave KA, Bertrand V, Nabirotchkin S, Cohen D, Demiot C, Magy L.

J Neuropathol Exp Neurol. 2018 Apr 1;77(4):274-281. doi: 10.1093/jnen/nly001.

PMID:
29408953
19.

Nerve Biopsy Is Still Useful in Some Inherited Neuropathies.

Duchesne M, Mathis S, Richard L, Magdelaine C, Corcia P, Nouioua S, Tazir M, Magy L, Vallat JM.

J Neuropathol Exp Neurol. 2018 Feb 1;77(2):88-99. doi: 10.1093/jnen/nlx111.

PMID:
29300988
20.

History and current difficulties in classifying inherited myopathies and muscular dystrophies.

Mathis S, Tazir M, Magy L, Duval F, Le Masson G, Duchesne M, Couratier P, Ghorab K, Solé G, Lacoste I, Goizet C, Vallat JM.

J Neurol Sci. 2018 Jan 15;384:50-54. doi: 10.1016/j.jns.2017.10.051. Epub 2017 Nov 2.

PMID:
29249377
21.

Autoimmune nodo-paranodopathies of peripheral nerve: the concept is gaining ground.

Uncini A, Vallat JM.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):627-635. doi: 10.1136/jnnp-2017-317192. Epub 2017 Dec 16. Review.

PMID:
29248893
22.

Involvement of the enteroendocrine system in intestinal obstruction.

Ballouhey Q, Richard L, Fourcade L, Ben Rhaiem I, Vallat JM, Sturtz F, Bourthoumieu S.

PLoS One. 2017 Nov 1;12(11):e0186507. doi: 10.1371/journal.pone.0186507. eCollection 2017.

23.

Did Jules Dejerine describe AMAN at the end of the 19th century?

Mathis S, Magy L, Le Masson G, Vallat JM.

Neurology. 2017 Oct 17;89(16):1749-1753. doi: 10.1212/WNL.0000000000004527.

PMID:
29038133
24.

Jules Dejerine and the peripheral nervous system.

Mathis S, Vallat JM.

Neurology. 2017 Aug 8;89(6):611-615. doi: 10.1212/WNL.0000000000004217.

PMID:
28784633
25.

Bovine and murine models highlight novel roles for SLC25A46 in mitochondrial dynamics and metabolism, with implications for human and animal health.

Duchesne A, Vaiman A, Castille J, Beauvallet C, Gaignard P, Floriot S, Rodriguez S, Vilotte M, Boulanger L, Passet B, Albaric O, Guillaume F, Boukadiri A, Richard L, Bertaud M, Timsit E, Guatteo R, Jaffrézic F, Calvel P, Helary L, Mahla R, Esquerré D, Péchoux C, Liuu S, Vallat JM, Boichard D, Slama A, Vilotte JL.

PLoS Genet. 2017 Apr 4;13(4):e1006597. doi: 10.1371/journal.pgen.1006597. eCollection 2017 Apr.

26.

CNTNAP1 mutations cause CNS hypomyelination and neuropathy with or without arthrogryposis.

Hengel H, Magee A, Mahanjah M, Vallat JM, Ouvrier R, Abu-Rashid M, Mahamid J, Schüle R, Schulze M, Krägeloh-Mann I, Bauer P, Züchner S, Sharkia R, Schöls L.

Neurol Genet. 2017 Mar 22;3(2):e144. doi: 10.1212/NXG.0000000000000144. eCollection 2017 Apr.

27.

Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy.

Maddur MS, Stephen-Victor E, Das M, Prakhar P, Sharma VK, Singh V, Rabin M, Trinath J, Balaji KN, Bolgert F, Vallat JM, Magy L, Kaveri SV, Bayry J.

J Neuroinflammation. 2017 Mar 20;14(1):58. doi: 10.1186/s12974-017-0818-5.

28.

Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome.

Mathis S, Magy L, Corcia P, Ghorab K, Richard L, Ciron J, Duchesne M, Vallat JM.

Case Rep Neurol Med. 2016;2016:6108234. doi: 10.1155/2016/6108234. Epub 2016 Dec 1.

29.

Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies.

Vallat JM, Yuki N, Sekiguchi K, Kokubun N, Oka N, Mathis S, Magy L, Sherman DL, Brophy PJ, Devaux JJ.

Neuromuscul Disord. 2017 Mar;27(3):290-293. doi: 10.1016/j.nmd.2016.10.008. Epub 2016 Oct 24.

30.

Contactin-Associated Protein 1 (CNTNAP1) Mutations Induce Characteristic Lesions of the Paranodal Region.

Vallat JM, Nizon M, Magee A, Isidor B, Magy L, Péréon Y, Richard L, Ouvrier R, Cogné B, Devaux J, Zuchner S, Mathis S.

J Neuropathol Exp Neurol. 2016 Dec 1;75(12):1155-1159. doi: 10.1093/jnen/nlw093.

31.

Two novel variants in CNTNAP1 in two siblings presenting with congenital hypotonia and hypomyelinating neuropathy.

Nizon M, Cogne B, Vallat JM, Joubert M, Liet JM, Simon L, Vincent M, Küry S, Boisseau P, Schmitt S, Mercier S, Bénéteau C, Larrose C, Coste M, Latypova X, Péréon Y, Mussini JM, Bézieau S, Isidor B.

Eur J Hum Genet. 2017 Jan;25(1):150-152. doi: 10.1038/ejhg.2016.142. Epub 2016 Oct 26.

32.

Sensory neuropathy in progressive motor neuronopathy (pmn) mice is associated with defects in microtubule polymerization and axonal transport.

Schäfer MK, Bellouze S, Jacquier A, Schaller S, Richard L, Mathis S, Vallat JM, Haase G.

Brain Pathol. 2017 Jul;27(4):459-471. doi: 10.1111/bpa.12422. Epub 2016 Oct 18.

PMID:
27488538
33.

Management and therapeutic perspectives in amyotrophic lateral sclerosis.

Mathis S, Couratier P, Julian A, Vallat JM, Corcia P, Le Masson G.

Expert Rev Neurother. 2017 Mar;17(3):263-276. doi: 10.1080/14737175.2016.1227705. Epub 2016 Sep 20. Review.

PMID:
27644548
34.

Monoclonal gammopathy of undeterminated significance and endoneurial IgG deposition: A case report.

Mathis S, Franques J, Richard L, Vallat JM.

Medicine (Baltimore). 2016 Sep;95(36):e4807. doi: 10.1097/MD.0000000000004807.

35.

Reasons Charcot-Marie-Tooth disease due to mutations in the MME gene should not be named AR-CMT2T.

Mathis S, Goizet C, Tazir M, Magy L, Vallat JM.

Ann Neurol. 2016 Sep;80(3):477. doi: 10.1002/ana.24741. Epub 2016 Aug 4. No abstract available.

PMID:
27458975
36.

Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.

Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, Franques J, Lefebvre MN, Ghorab K, Al-Moussawi M, Tiffreau V, Preudhomme M, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Gilbert W, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Grès C, Nabirotchkin S, Guedj M, Chumakov I, Cohen D.

Orphanet J Rare Dis. 2016 Jul 7;11(1):92. No abstract available.

37.

Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies.

Vallat JM, Magy L, Ciron J, Corcia P, Le Masson G, Mathis S.

Expert Rev Neurother. 2016 Sep;16(9):1111-9. doi: 10.1080/14737175.2016.1198257. Epub 2016 Jun 16. Review.

PMID:
27267749
38.

Classifications of neurogenetic diseases: An increasingly complex problem.

Vallat JM, Goizet C, Tazir M, Couratier P, Magy L, Mathis S.

Rev Neurol (Paris). 2016 Jun-Jul;172(6-7):339-49. doi: 10.1016/j.neurol.2016.04.005. Epub 2016 May 27. Review.

PMID:
27240993
39.

Congenital hypomyelinating neuropathy due to the association of a truncating mutation in PMP22 with the classical HNPP deletion.

Jouaud M, Gonnaud PM, Richard L, Latour P, Ollagnon-Roman E, Sturtz F, Mathis S, Magy L, Vallat JM.

Neuromuscul Disord. 2016 Apr-May;26(4-5):316-21. doi: 10.1016/j.nmd.2016.01.004. Epub 2016 Apr 5.

PMID:
27067623
40.

Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.

Mathis S, Vallat JM, Magy L.

Immunotherapy. 2016 Feb;8(2):165-78. doi: 10.2217/imt.15.107. Epub 2016 Jan 25. Review.

PMID:
26809024
41.

Simultaneous Quantification of Unmyelinated Nerve Fibers in Sural Nerve and in Skin.

Duchesne M, Magy L, Richard L, Ingrand P, Neau JP, Mathis S, Vallat JM.

J Neuropathol Exp Neurol. 2016 Jan;75(1):53-60. doi: 10.1093/jnen/nlv005. Epub 2015 Dec 7.

PMID:
26705410
42.

Too many numbers and complexity: time to update the classifications of neurogenetic disorders?

Vallat JM, Goizet C, Magy L, Mathis S.

J Med Genet. 2016 Oct;53(10):647-50. doi: 10.1136/jmedgenet-2015-103477. Epub 2015 Oct 30. No abstract available.

PMID:
26518709
43.

Charcot-Marie-Tooth diseases: an update and some new proposals for the classification.

Mathis S, Goizet C, Tazir M, Magdelaine C, Lia AS, Magy L, Vallat JM.

J Med Genet. 2015 Oct;52(10):681-90. doi: 10.1136/jmedgenet-2015-103272. Epub 2015 Aug 5. Review.

PMID:
26246519
44.

Boundary Caps Give Rise to Neurogenic Stem Cells and Terminal Glia in the Skin.

Gresset A, Coulpier F, Gerschenfeld G, Jourdon A, Matesic G, Richard L, Vallat JM, Charnay P, Topilko P.

Stem Cell Reports. 2015 Aug 11;5(2):278-90. doi: 10.1016/j.stemcr.2015.06.005. Epub 2015 Jul 23.

45.

Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.

Magy L, Kaboré R, Mathis S, Lebeau P, Ghorab K, Caudie C, Vallat JM.

J Immunol Res. 2015;2015:450391. doi: 10.1155/2015/450391. Epub 2015 May 6.

46.

[Peripheral neuropathies].

Magy L, Vallat JM.

Rev Prat. 2015 Apr;65(4):569-76. French. No abstract available.

PMID:
26058212
47.

Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.

Vallat JM, Mathis S, Ghorab K, Milor MA, Richard L, Magy L.

Eur Neurol. 2015;73(5-6):294-302. doi: 10.1159/000381767. Epub 2015 Apr 29.

PMID:
25925430
48.

Therapeutic options in Charcot-Marie-Tooth diseases.

Mathis S, Magy L, Vallat JM.

Expert Rev Neurother. 2015 Apr;15(4):355-66. doi: 10.1586/14737175.2015.1017471. Epub 2015 Feb 21. Review.

PMID:
25703094
49.

Value of nerve biopsy in patients with latent malignant hemopathy and peripheral neuropathy: a case series.

Duchesne M, Mathis S, Corcia P, Richard L, Ghorab K, Jaccard A, Magy L, Vallat JM.

Medicine (Baltimore). 2015 Jan;94(3):e394. doi: 10.1097/MD.0000000000000394.

50.

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.

Attarian S, Vallat JM, Magy L, Funalot B, Gonnaud PM, Lacour A, Péréon Y, Dubourg O, Pouget J, Micallef J, Franques J, Lefebvre MN, Ghorab K, Al-Moussawi M, Tiffreau V, Preudhomme M, Magot A, Leclair-Visonneau L, Stojkovic T, Bossi L, Lehert P, Gilbert W, Bertrand V, Mandel J, Milet A, Hajj R, Boudiaf L, Scart-Grès C, Nabirotchkin S, Guedj M, Chumakov I, Cohen D.

Orphanet J Rare Dis. 2014 Dec 18;9:199. doi: 10.1186/s13023-014-0199-0. Erratum in: Orphanet J Rare Dis. 2016;11(1):92.

Supplemental Content

Loading ...
Support Center